Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fosamax for Osteoporosis in Non-walking Children With Cerebral Palsy
NCT00822029Phase 3Terminated
- Sponsor
- Institut Curie - Department of Clinical Research and Innovation
- Start
- Feb 2009
- Primary completion
- Feb 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in osteoporosis comparing Fosamax with Placebo (2 arms). Primary endpoint: Bone Mineral Density at 1 year. Started Feb 2009; status: terminated.
02
Drugs
alendronate
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT00822029.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00822029.